Published in
Elsevier, EBioMedicine, (55), p. 102779, 2020
DOI: 10.1016/j.ebiom.2020.102779
Links
Tools
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
Journal article published in 2020 by
Rosa De Miguel 
,
David Rial-Crestelo,
Lourdes Dominguez-Dominguez,
Rocío Montejano ,
Andrés Esteban-Cantos,
Paula Aranguren-Rivas,
Natalia Stella-Ascariz,
Otilia Bisbal,
Laura Bermejo-Plaza,
Mónica Garcia-Alvarez,
Belén Alejos,
Asunción Hernando ,
Mireia Santacreu-Guerrero,
Julen Cadiñanos ,
Mario Mayoral
and other authors.
,
David Rial-Crestelo,
Lourdes Dominguez-Dominguez,
Rocío Montejano ,
Andrés Esteban-Cantos,
Paula Aranguren-Rivas,
Natalia Stella-Ascariz,
Otilia Bisbal,
Laura Bermejo-Plaza,
Mónica Garcia-Alvarez,
Belén Alejos,
Asunción Hernando ,
Mireia Santacreu-Guerrero,
Julen Cadiñanos ,
Mario Mayoral
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 